Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

ClinicalTrials.gov ID: NCT06128369

Public ClinicalTrials.gov record NCT06128369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Ophthalmic Suspension in the Treatment of Inflammation and Pain Following Cataract Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was a randomized, double-masked, vehicle-controlled, Phase 3 study evaluating the efficacy and safety of OCS-01 QD compared to vehicle in the treatment of inflammation and pain following cataract surgery.

Study identification

NCT ID
NCT06128369
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Oculis
Industry
Enrollment
117 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 18, 2023 (Actual)
Primary completion
May 2, 2024 (Actual)
Completion
May 9, 2024 (Actual)
Last update posted
Jul 30, 2026

2023 – 2024

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Oculis Investigative Site Glendale California 91204 —
Oculis Investigative Site Inglewood California 90301 —
Oculis Investigative Site Newport Beach California 92663 —
Oculis Investigative Site Torrance California 90505 —
Oculis Investigative Site Tamarac Florida 33321 —
Oculis Investigative Site Morrow Georgia 30260 —
Oculis Investigative Site Northbrook Illinois 60062 —
Oculis Investigative Site Indianapolis Indiana 46240 —
Oculis Investigative Site Louisville Kentucky 40206 —
Oculis Investigative Site Woburn Massachusetts 01810 —
Oculis Investigative Site St Louis Missouri 63131 —
Oculis Investigative Site Washington Missouri 63090 —
Oculis Investigative Site Las Vegas Nevada 89145 —
Oculis Investigative Site Elizabeth City North Carolina 27909 —
Oculis Investigative Site Leland North Carolina 28451 —
Oculis Investigative Site Cincinnati Ohio 45242 —
Oculis Investigative Site Eugene Oregon 97401 —
Oculis Investigative Site Erie Pennsylvania 16507 —
Oculis Investigative Site Kingston Pennsylvania 18704 —
Oculis Investigative Site Nashville Tennessee 37212 —
Oculis Investigative Site Austin Texas 78731 —
Oculis Investigative Site Houston Texas 77008 —
Oculis Investigative Site San Antonio Texas 78229 —
Oculis Investigative Site Lynchburg Virginia 24502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06128369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06128369 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →